Cargando…

The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis

BACKGROUND: This study determined whether the survival of lung cancer (LC) patients with rheumatoid arthritis (RA) is differed by histological subtype. MATERIALS: This observational, retrospective study compared the LC survival rate of 34 RA patients with that of 132 age- and sex-matched patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong Won, Choi, Jiin, Chung, Sung Jun, Park, Tai Sun, Lee, Hyun, Moon, Ji-Yong, Kim, Sang-Heon, Kim, Tae-Hyung, Yoon, Ho Joo, Sohn, Jang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798490/
https://www.ncbi.nlm.nih.gov/pubmed/35117622
http://dx.doi.org/10.21037/tcr.2020.03.02
_version_ 1784641819951235072
author Park, Dong Won
Choi, Jiin
Chung, Sung Jun
Park, Tai Sun
Lee, Hyun
Moon, Ji-Yong
Kim, Sang-Heon
Kim, Tae-Hyung
Yoon, Ho Joo
Sohn, Jang Won
author_facet Park, Dong Won
Choi, Jiin
Chung, Sung Jun
Park, Tai Sun
Lee, Hyun
Moon, Ji-Yong
Kim, Sang-Heon
Kim, Tae-Hyung
Yoon, Ho Joo
Sohn, Jang Won
author_sort Park, Dong Won
collection PubMed
description BACKGROUND: This study determined whether the survival of lung cancer (LC) patients with rheumatoid arthritis (RA) is differed by histological subtype. MATERIALS: This observational, retrospective study compared the LC survival rate of 34 RA patients with that of 132 age- and sex-matched patients without RA who received medical care from 2011 to 2016. Survival curves were generated using the Kaplan-Meier method. Cox proportional hazards regression analyses were used to estimate hazard ratios and determine risk factors predicting mortality according to histological subtype, including small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). RESULTS: The predominant histological subtype was adenocarcinoma in both groups, however, a larger proportion of SCLC patients was noted in patients with both LC and RA, compared to those with LC but without RA (26.5% vs. 12.9%, respectively; P=0.0317). LC patients with RA had a significantly lower body mass index (P=0.0488), and a higher proportion of interstitial lung disease (P<0.0001), compared to patients without RA. There was no statistical difference in the distribution of smoking status, stage, or comorbidity index between groups. Overall survival did not differ between LC patients with and without RA. Mortality was significantly worse for RA patients with SCLC than those with NSCLC (P=0.0404), and RA was associated with a 3.26-fold increase in mortality for SCLC patients with versus without RA (P=0.0350; 95% confidence interval: 1.05–9.56). However, RA was not a risk factor for mortality in NSCLC and, even in histological subtypes including lung adenocarcinoma and squamous cell carcinoma. CONCLUSIONS: RA was not associated with a lower overall survival rate for LC patients, irrespective of histological subtype. Because the effects of RA on LC mortality might differ between SCLC and NSCLC patients, future studies should recognize that the histological subtype may affect the outcome.
format Online
Article
Text
id pubmed-8798490
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87984902022-02-02 The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis Park, Dong Won Choi, Jiin Chung, Sung Jun Park, Tai Sun Lee, Hyun Moon, Ji-Yong Kim, Sang-Heon Kim, Tae-Hyung Yoon, Ho Joo Sohn, Jang Won Transl Cancer Res Original Article BACKGROUND: This study determined whether the survival of lung cancer (LC) patients with rheumatoid arthritis (RA) is differed by histological subtype. MATERIALS: This observational, retrospective study compared the LC survival rate of 34 RA patients with that of 132 age- and sex-matched patients without RA who received medical care from 2011 to 2016. Survival curves were generated using the Kaplan-Meier method. Cox proportional hazards regression analyses were used to estimate hazard ratios and determine risk factors predicting mortality according to histological subtype, including small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). RESULTS: The predominant histological subtype was adenocarcinoma in both groups, however, a larger proportion of SCLC patients was noted in patients with both LC and RA, compared to those with LC but without RA (26.5% vs. 12.9%, respectively; P=0.0317). LC patients with RA had a significantly lower body mass index (P=0.0488), and a higher proportion of interstitial lung disease (P<0.0001), compared to patients without RA. There was no statistical difference in the distribution of smoking status, stage, or comorbidity index between groups. Overall survival did not differ between LC patients with and without RA. Mortality was significantly worse for RA patients with SCLC than those with NSCLC (P=0.0404), and RA was associated with a 3.26-fold increase in mortality for SCLC patients with versus without RA (P=0.0350; 95% confidence interval: 1.05–9.56). However, RA was not a risk factor for mortality in NSCLC and, even in histological subtypes including lung adenocarcinoma and squamous cell carcinoma. CONCLUSIONS: RA was not associated with a lower overall survival rate for LC patients, irrespective of histological subtype. Because the effects of RA on LC mortality might differ between SCLC and NSCLC patients, future studies should recognize that the histological subtype may affect the outcome. AME Publishing Company 2020-04 /pmc/articles/PMC8798490/ /pubmed/35117622 http://dx.doi.org/10.21037/tcr.2020.03.02 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Park, Dong Won
Choi, Jiin
Chung, Sung Jun
Park, Tai Sun
Lee, Hyun
Moon, Ji-Yong
Kim, Sang-Heon
Kim, Tae-Hyung
Yoon, Ho Joo
Sohn, Jang Won
The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title_full The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title_fullStr The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title_full_unstemmed The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title_short The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
title_sort utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798490/
https://www.ncbi.nlm.nih.gov/pubmed/35117622
http://dx.doi.org/10.21037/tcr.2020.03.02
work_keys_str_mv AT parkdongwon theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT choijiin theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT chungsungjun theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT parktaisun theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT leehyun theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT moonjiyong theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT kimsangheon theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT kimtaehyung theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT yoonhojoo theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT sohnjangwon theutilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT parkdongwon utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT choijiin utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT chungsungjun utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT parktaisun utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT leehyun utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT moonjiyong utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT kimsangheon utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT kimtaehyung utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT yoonhojoo utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis
AT sohnjangwon utilityofhistologicalsubtypeforpredictingsurvivaloflungcancerpatientswithrheumatoidarthritis